Additionally, an increase in the number of CD19+CD5+ cells, as well as anti-angiotensin II type 1 receptor antibody activity (AT1-AA), has been observed in the serum of patients with preeclampsia. This evidence concerns the gene AGTR1 and preeclampsia.